Ichor Life Sciences

1. Is reported quantity based on absolute calibration against a reference standard, or relative/normalized signal? Quantitation is performed using an external reference standard of the same target material. The entire reference-standard vial, typically containing material of high chromatographic purity, is reconstituted in a defined volume to prepare a concentrated stock solution. This stock is subsequently diluted to the target analytical concentration. The HPLC-UV peak area of the test sample is compared with the peak area of the matched reference standard, and the sample concentration is calculated from the peak-area ratio and applicable dilution factors. The calculated concentration is then used to determine the inferred amount of peptide in the test vial. 2. Do you average replicate injections or preparations before reporting a single value? The reference standard is analyzed in replicate at the beginning of the assay to evaluate injection repeatability and system suitability. The acceptance criterion is ≤1% RSD for reference-standard peak area and retention time. Test samples are normally analyzed using a single injection. If a test-sample response differs substantially from the matched reference standard, including a difference greater than approximately 20%, the result is reviewed and the sample may be re-prepared and/or re-analyzed to confirm the result. 3. Do you assume full recovery of peptide upon reconstitution, or do you measure recovery implicitly? Full recovery is assumed. 4. Do you correct for adsorption, losses, or degradation, or are these reflected in the final number? No correction factors are applied for adsorption, incomplete recovery, handling losses, or degradation. Any such losses that occur before HPLC analysis would generally reduce the measured target-peptide concentration and therefore be reflected in the reported result. Samples are maintained under refrigerated or frozen storage conditions appropriate for the target and are analyzed promptly after reconstitution to minimize these effects; however, the magnitude of these potential losses is not independently measured as part of the routine assay. 5. Which detector(s) are used for quantification (UV, MS, both), and which signal is authoritative for quantity? HPLC-UV is the quantitative method. For peptide samples, a photodiode-array UV detector is operated at 215 nm to monitor peptide-bond absorbance, and the integrated target-peak area at this wavelength is used for quantitative calculations. For non-peptide targets, an alternative quantitation wavelength may be selected based on the UV absorbance spectrum of the analyte. Mass spectrometry is used as an orthogonal identity-confirmation method and is not used for quantitative determination in this assay. Peptide samples are analyzed by direct infusion under positive electrospray-ionization conditions, and the experimentally determined neutral monoisotopic mass is compared with the theoretical monoisotopic mass calculated from the peptide sequence. 6. How is purity incorporated into quantity (e.g., normalization vs independent measurement)? Purity and quantitative content are determined independently. Chromatographic purity is calculated as the integrated area of the target peptide peak divided by the total integrated area of detected chromatographic peaks and is reported as an HPLC-UV area percentage. Quantitative content is determined separately by comparing the target peptide peak area with that of the external reference standard. The chromatographic purity percentage is therefore not applied as a correction or normalization factor to the calculated peptide content. 7. What is your stated margin of error for this peptide, and does it include preparation + calibration uncertainty? A formal overall measurement uncertainty or margin of error has not been established for this assay. The ≤1% RSD system-suitability criterion applies to replicate reference-standard injections and represents instrument/injection repeatability; it should not be interpreted as a ±1% uncertainty for the reported peptide content. Overall assay uncertainty would additionally include contributions from reference-standard assignment, standard and sample preparation, reconstitution volume, dilution accuracy, recovery, chromatographic integration, and between-run variability. 8. Are reported values rounded, truncated, or raw calculated outputs? Reported quantitative values are rounded to the stated number of decimal places rather than reported as unrounded instrument outputs. For the current reporting format, HPLC purity and peptide content are generally reported to two decimal places. Calculations are performed using the underlying unrounded values before the final result is rounded for reporting. 9. Does your reported “mg per vial” represent recovered mass, inferred mass, or label-equivalent mass? The reported mg-per-vial value represents the analytically inferred amount of target peptide in the vial. The concentration of peptide measured in the reconstituted solution by comparison with the external reference standard is multiplied by the known reconstitution volume and applicable dilution factors to calculate the corresponding total mass in the original vial. It is not a direct gravimetric measurement of recovered peptide mass. Because quantitative recovery during reconstitution is assumed, losses caused by incomplete dissolution, adsorption, degradation, or sample handling are not independently corrected. 10. Under what conditions would you expect two vials from the same batch to differ by <1%? Two vials from the same batch would be expected to produce results within 1% of one another only where both the manufacturing process and the analytical method demonstrate sufficiently low variability. The current RSD criterion for replicate standard injections alone is not sufficient to establish that true vial-to-vial differences below 1% can be reliably resolved. A less than 1% variability could occur in identically filled vessels as a results of handling and storage conditions, and minor solvent delivery variations in the equipment used for reconstitution and dilution of the standards or analytical samples.